**Summary:**
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, Government of India, is convening a meeting with all manufacturers of Oxytocin formulations for human and animal use. The meeting is scheduled for February 22, 2018, at 11:00 AM at Malviya Bhawan, Deen Dayal Upadhyaya Marg, New Delhi. The purpose of the meeting is to address the reported misuse of Oxytocin by farmers and dairy owners for extracting milk from milch animals, as well as cases of illegal manufacture, import, and sale of the drug. The CDSCO and the Ministry of Health and Family Welfare have taken various measures to curb this misuse. This meeting aims to discuss further appropriate measures to prevent the misuse of Oxytocin. Manufacturers are requested to depute a representative to attend. Confirmation of attendance should be sent to dci@nic.in. The meeting is being organized by Dr. S. Eswara Reddy, Joint Drugs Controller.
Key Entities Referenced
Central Drugs Standard Control Organization: A national regulatory body for pharmaceuticals and medical devices in India.
Drugs Controller General India: The head of the Central Drugs Standard Control Organization (CDSCO) in India.
Oxytocin: A drug formulation that is the subject of the meeting due to its misuse.
Ministry of Health and Family Welfare: A government ministry responsible for health policy in India.
New Delhi: The location of the meeting and various government offices mentioned in the document; A city and union territory of India.
Malviya Bhawan: The venue of the meeting in New Delhi.
Dr. S. Eswara Reddy: Joint Drugs Controller, signatory of the meeting notice.
Ghaziabad, Uttar Pradesh: Location of IPC (Indian Pharmacopoeia Commission), requested for logistic support.
File No. X11026/40/2018-BD
GOVERNMENT OF INDIA
Directorate General of Health Services
Central Drugs Standard Control Organization
Office of Drugs Controller General (India)
FDA Bhawan, Kotla Road,
New Delhi-110002
Dated
{ 5 rep
MEETING NOTICE
Subject: Meeting of CDSCO with Manufacturers of Oxytocin Formulation to
discuss issues related to misuse of Oxytocin - reg.
Sir,
Reports have appeared from time to time in various fora about misuse of
Oxytocin in the country by the farmers and dairy owners to extract milk from
milch animals.
Cases of illegal manufacture, import and sale of the drug and its misuse by the
farmers or dairy owners have also been unearthed from time to time in different
parts of the country.
Various measures have been taken by CDSCO and Ministry of Health and Family
Welfare, Govt. of India to curb such misuse of the drug.
In this regard , a meeting of all manufacturers of Oxytocin formulation for
human and animal use, with CDSCO has been convened on 224 February, 2018
at 11.00 AM at Malviya Bhawan , Deen Dayal Upadhyaya Marg, New Delhi to
discuss the matter for taking appropriate measures to prevent the misuse of
Oxytocin.
You are requested to make it convenient to depute one of your representatives to
attend the meeting.
A line of confirmation in the Email: dci@nic.in shall be appreciated .
(Dr. S. Eswara Reddy)
Joint Drugs Controller (I)
To
All the manufacturers of Oxytocin formulation for human and animal
use.
Copy to:
1. IDMA/OPPI/FOPE/CIPI/INFAH
2. IPC, Ghaziabad with a request for logistic support.
3. IT CELL for uploading in CDSCO WEBSITE
Copy for information:
PPS to JS(R), Ministry of Health and Family Welfare ,Nirman Bhavan New
Delhi